Latest Breaking News On - Franziska michor - Page 1 : vimarsana.com

Exscientia plc (EXAI) Terminates CEO Andrew Hopkins

Exscientia Fires CEO for "Inappropriate" Relationships with Two Employees

Study Finds Associations Between T Cell Diversity in Peripheral Blood and Patient Age, Stage of Breast Cancer Development

Researchers at Dana-Farber Cancer Institute found that the diversity of T cells in peripheral blood declines with age in patients with breast cancer and, in younger patients, is lower in those diagnosed with metastatic disease than with ductal carcinoma in situ.

Study Finds Associations Between T Cell Diversity in Peripheral Blood and Patient Age and Stage of Breast Cancer Development

Researchers at Dana-Farber Cancer Institute have found that the diversity of T cells in peripheral blood declines with age in patients with breast cancer and, in younger patients, is lower in those diagnosed with metastatic disease than with ductal carcinoma in situ.

Exscientia Business Update for Second Quarter and First Half of 2023

Exscientia plc Recent advancements in the Company’s pipeline, collaborations and operations, as well as financial results for the second quarter and first half 2023, are summarised below.. -Today at 07:03 am- MarketScreener

Harbinger Health Announces Results Demonstrating High-Sensitivity of Early Stage Multi-Cancer Detection Platform at ASCO Annual Meeting 2023

Overall sensitivity of early cancer detection for novel blood-based assay was 82% at 95% specificity; specific cancer detection rates include colorectal (96%),.

Harbinger Health Announces Results Demonstrating High-Sensitivity of Early Stage Multi-Cancer Detection Platform at ASCO Annual Meeting 2023

Harbinger Health Announces Results Demonstrating High-Sensitivity of Early Stage Multi-Cancer Detection Platform at ASCO Annual Meeting 2023

Overall sensitivity of early cancer detection for novel blood-based assay was 82% at 95% specificity; specific cancer detection rates include colo.

2nd Transatlantic Exchange Program focusses on Artificial Intelligence and Data Science in Oncology

Exscientia plc: Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors

- Renowned thought leader in computational biology and data science for cancer research - - Over 180 publications on the evolutionary dynamics of cancer initiation, progression, response to therapy